Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study

Tricou, Vianney; Essink, Brandon; Ervin, John; Turner, M.; Escudero, Ian; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Borkowski, Astrid; Wallace, Derek

doi:10.1371/journal.pntd.0011124

Public

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study

Published in PLoS neglected tropical diseases • Mar 8, 2023

Authors:

Vianney Tricou

Brandon Essink

John Ervin

Abstract

BACKGROUND: Yellow fever (YF) vaccination is often mandatory for travelers to YF-endemic areas. The areas with risk of YF partially overlap with those of dengue, for which there is currently no recommended vaccine available for dengue-naïve individuals. This phase 3 study assessed the immunogenicity...

Subject

Immunogenicity

Dengue fever

Dengue vaccine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!